GPNs struggle to negotiate their pay, terms and conditions because they are constrained by ‘medical and managerial hegemony’ ...

Daiichi and Merck saw the highest ORR—57.1%—in patients who received the top dose of R-DXd. Yet the drugmakers have opted to ...

The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical worsening among adults with pulmonary arterial hypertension (PAH) who were ...

One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy in 16 patients with metastatic uveal ...

Dato-DXd showed a 43% reduction in disease progression risk and a 21% reduction in death risk compared to chemotherapy in TNBC patients ineligible for immunotherapy. The TROPION-Breast02 trial ...

Recent advances in high-throughput recombinant production are transforming therapeutic antibody development strategies. As a result of improved expression platforms, including smaller volumes, ...

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. , will share new data on zoliflodacin during the Infectious Disease Society of America's IDWeek 2025 annual meeting in Atlanta, GA, ...

Dr. Susanna Naggie, Director of Infectious Diseases at the Duke Clinical Research Institute, with colleagues and ...

Here is an in-depth timeline on the baseball life of former Yankees catcher Jesus Montero, who died on Sunday at age 35.

After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal ...

Cardiologists often struggle to assess heart attack risk. New startups using AI could help.

Retail buzz spiked around Gilead Sciences Inc. after the biotech firm on Sunday revealed new data showing that its cancer ...